The Oncosearch | Oncotarget

Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features Research Paper

Elina Jokinen, Niina Laurila, Peppi Koivunen, Jussi P. Koivunen

Published Sep 2, 2014 · Vol. 5, No. 19 · pp. 9295-9307

Mutant NRAS^Q61 shares signaling similarities across various cancer types â€“ potential implications for future therapies Research Paper

Igor Vujic, Christian Posch, Martina Sanlorenzo, Adam J. Yen, Aaron Tsumura, Andrew Kwong, Valentin Feichtenschlager, Kevin Lai, Douglas V. Arneson, Klemens Rappersberger, Susana M. Ortiz-Urda

Published Aug 8, 2014 · Vol. 5, No. 17 · pp. 7936-7944

A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice Research Paper

Therese Liechtenstein, Noemi Perez-Janices, Maria Gato, Fabio Caliendo, Grazyna Kochan, Idoia Blanco-Luquin, Frederick Arce, David Guerrero-Setas, Joaquin Fernandez-Irigoyen, Enrique Santamaria, Karine Breckpot, David Escors

Published Aug 4, 2014 · Vol. 5, No. 17 · pp. 7843-7857

Critical role of STAT3 in melanoma metastasis through anoikis resistance Research Paper

Neel M. Fofaria, Sanjay K. Srivastava

Published Jul 25, 2014 · Vol. 5, No. 16 · pp. 7051-7064

AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells Research Paper

Sarah K. Maenhout, Stephanie Du Four, Jurgen Corthals, Bart Neyns, Kris Thielemans, Joeri L. Aerts

Published Jul 25, 2014 · Vol. 5, No. 16 · pp. 6801-6815

Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway Research Paper

Qingling Li, Jie Li, Ting Wen, Weiqi Zeng, Cong Peng, Siyu Yan, Jieqiong Tan, Keda Yang, Shuang Liu, Aiyuan Guo, Chong Zhang, Juan Su, Minghao Jiang, Zhaoqian Liu, Honghao Zhou, Xiang Chen

Published Jul 15, 2014 · Vol. 5, No. 15 · pp. 6387-6403

Cdc6 cooperates with c-Myc to promote genome instability and epithelial to mesenchymal transition (EMT) in zebrafish Research Paper

Ching-Hung Chen, Dar-Shong Lin, Chieh-Wen Cheng, Chun-Ju Lin, Yu-Kang Lo, Chueh-Chuan Yen, Alan Yueh-Luen Lee, Chung-Der Hsiao

Published Jul 11, 2014 · Vol. 5, No. 15 · pp. 6300-6311

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma Research Paper

Aparna Jayachandran, Matthew Anaka, Prashanth Prithviraj, Christopher Hudson, Sonja J. McKeown, Pu-Han Lo, Laura J. Vella, Colin R. Goding, Jonathan Cebon, Andreas Behren

Published Jul 8, 2014 · Vol. 5, No. 14 · pp. 5782-5797

Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway Research Paper

Harish Potu, Luke F. Peterson, Anupama Pal, Monique Verhaegen, Juxiang Cao, Moshe Talpaz, Nicholas J. Donato

Published Jun 26, 2014 · Vol. 5, No. 14 · pp. 5559-5569

A novel tumor suppressor function of Kindlin-3 in solid cancer Research Paper

Ibtissem Djaafri, Farah Khayati, Suzanne Menashi, Jorg Tost, Marie-Pierre Podgorniak, Aurelie Sadoux, Antoine Daunay, Luis Teixeira, Jean Soulier, Ahmed Idbaih, Niclas Setterblad, FranÃ§oise Fauvel, Fabien Calvo, Anne Janin, Celeste LebbÃ©, Samia Mourah

Published Jun 20, 2014 · Vol. 5, No. 19 · pp. 8970-8985

The MAPK pathway as an apoptosis enhancer in melanoma Research Paper

Johannes M. Haydn, Anita Hufnagel, Johannes Grimm, Katja Maurus, Manfred Schartl, Svenja Meierjohann

Published Jun 8, 2014 · Vol. 5, No. 13 · pp. 5040-5053

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals Research Paper

Laura Gatti, Alexandra Sevko, Michelandrea De Cesare, Noemi Arrighetti, Giacomo Manenti, Emilio Ciusani, Paolo Verderio, Chiara M. Ciniselli, Denis Cominetti, Nives Carenini, Elisabetta Corna, Nadia Zaffaroni, Monica Rodolfo, Licia Rivoltini, Viktor Umansky, Paola Perego

Published Jun 6, 2014 · Vol. 5, No. 12 · pp. 4516-4528

A highly recurrent RPS27 5â€™UTR mutation in melanoma Priority Research Paper

Ken Dutton-Regester, Jared J. Gartner, Rafi Emmanuel, Nouar Qutob, Michael A. Davies, Jeffrey E. Gershenwald, William Robinson, Steven Robinson, Steven A. Rosenberg, Richard A. Scolyer, Graham J. Mann, John F. Thompson, Nicholas K. Hayward, Yardena Samuels

Published Jun 1, 2014 · Vol. 5, No. 10 · pp. 2912-2917

Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk Research Paper

Wenqiang Cao, Xiaoling Li, Shanyuan Zheng, Wenjie Zheng, Yum-shing Wong, Tianfeng Chen

Published May 26, 2014 · Vol. 5, No. 17 · pp. 7431-7445

Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme Research Paper

Anna Laurenzana, Alessio Biagioni, Silvia Dâ€™Alessio, Francesca Bianchini, Anastasia ChillÃ, Francesca Margheri, Cristina Luciani, Benedetta Mazzanti, Nicola Pimpinelli, Eugenio Torre, Silvio Danese, Lido Calorini, Mario Del Rosso, Gabriella Fibbi

Published May 19, 2014 · Vol. 5, No. 11 · pp. 3711-3727

CD271 is an imperfect marker for melanoma initiating cells Research Paper

Yann Cheli, Vanessa F. Bonnazi, Arnaud Jacquel, Maryline Allegra, Gian Marco De Donatis, Philippe Bahadoran, Corine Bertolotto, Robert Ballotti

Published May 13, 2014 · Vol. 5, No. 14 · pp. 5272-5283

Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases Research Paper

Fatma Sfaxi, Nathalie Scamuffa, Claude Lalou, Jia Ma, Peter Metrakos, GÃ©raldine Siegfried, Hermann Ragg, Andreas Bikfalvi, Fabien Calvo, Abdel-Majid Khatib

Published May 13, 2014 · Vol. 5, No. 12 · pp. 4195-4210

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy Research Paper

Rachel Abbotts, Rosalyn Jewell, JÃ©rÃ©mie Nsengimana, David J. Maloney, Anton Simeonov, Claire Seedhouse, Faye Elliott, Jon Laye, Christy Walker, Ajit Jadhav, Anna Grabowska, Graham Ball, Poulam M. Patel, Julia Newton-Bishop, David M. Wilson III, Srinivasan Madhusudan

Published Apr 27, 2014 · Vol. 5, No. 10 · pp. 3273-3286

An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities Research Paper

Yair Tal, Shlomo Yaakobi, Miryam Horovitz-Fried, Einav Safyon, Benyamin Rosental, Angel Porgador, Cyrille J. Cohen

Published Apr 24, 2014 · Vol. 5, No. 21 · pp. 10949-10958

Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach Research Paper

Chandra K. Singh, Jasmine George, Minakshi Nihal, Grzegorz Sabat, Raj Kumar, Nihal Ahmad

Published Apr 12, 2014 · Vol. 5, No. 7 · pp. 1987-1999

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features Research Paper

Mutant NRAS^Q61 shares signaling similarities across various cancer types â€“ potential implications for future therapies Research Paper

A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice Research Paper

Critical role of STAT3 in melanoma metastasis through anoikis resistance Research Paper

AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells Research Paper

Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway Research Paper

Cdc6 cooperates with c-Myc to promote genome instability and epithelial to mesenchymal transition (EMT) in zebrafish Research Paper

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma Research Paper

Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway Research Paper

A novel tumor suppressor function of Kindlin-3 in solid cancer Research Paper

The MAPK pathway as an apoptosis enhancer in melanoma Research Paper

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals Research Paper

A highly recurrent RPS27 5â€™UTR mutation in melanoma Priority Research Paper

Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk Research Paper

Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme Research Paper

CD271 is an imperfect marker for melanoma initiating cells Research Paper

Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases Research Paper

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy Research Paper

An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities Research Paper

Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features Research Paper

Mutant NRASQ61 shares signaling similarities across various cancer types â€“ potential implications for future therapies Research Paper

A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice Research Paper

Critical role of STAT3 in melanoma metastasis through anoikis resistance Research Paper

AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells Research Paper

Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway Research Paper

Cdc6 cooperates with c-Myc to promote genome instability and epithelial to mesenchymal transition (EMT) in zebrafish Research Paper

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma Research Paper

Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway Research Paper

A novel tumor suppressor function of Kindlin-3 in solid cancer Research Paper

The MAPK pathway as an apoptosis enhancer in melanoma Research Paper

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals Research Paper

A highly recurrent RPS27 5â€™UTR mutation in melanoma Priority Research Paper

Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk Research Paper

Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme Research Paper

CD271 is an imperfect marker for melanoma initiating cells Research Paper

Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases Research Paper

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy Research Paper

An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities Research Paper

Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach Research Paper

Mutant NRAS^Q61 shares signaling similarities across various cancer types â€“ potential implications for future therapies Research Paper